Search references for CONATUMUMAB. Phrases containing CONATUMUMAB
See searches and references containing CONATUMUMAB!CONATUMUMAB
Monoclonal antibody
Conatumumab (originally AMG-655) is a monoclonal antibody developed for the treatment of cancer. It is a fully human monoclonal agonist antibody directed
Conatumumab
Immune system messenger protein which induces inflammation
proteins: Ardenermin Dulanermin Antibodies: Belimumab Brentuximab vedotin Conatumumab Dacetuzumab Denosumab Drozitumab Enavatuzumab Iratumumab Lexatumumab
Tumor_necrosis_factor
humanized PTK7 cancer Coltuximab ravtansine mab chimeric CD19 cancer Conatumumab mab human TRAIL-R2 cancer Concizumab Alhemo mab humanized tissue factor
List of therapeutic monoclonal antibodies
List_of_therapeutic_monoclonal_antibodies
Protein superfamily of cytokine receptors
proteins: Ardenermin Dulanermin Antibodies: Belimumab Brentuximab vedotin Conatumumab Dacetuzumab Denosumab Drozitumab Enavatuzumab Iratumumab Lexatumumab
TNF_receptor_superfamily
compound solution of sodium lactate (INN) Compro Comtan Comtrex Comvax conatumumab (USAN, INN) conbercept (INN) Concentraid Conceptrol Concerta concizumab
List_of_drugs:_Cm–Co
Experiment TNFα inhibitor
proteins: Ardenermin Dulanermin Antibodies: Belimumab Brentuximab vedotin Conatumumab Dacetuzumab Denosumab Drozitumab Enavatuzumab Iratumumab Lexatumumab
Pegipanermin
Monoclonal antibody
(+hyaluronidase) Ascrinvacumab§ Balstilimab† Botensilimab Cixutumumab§ Conatumumab§ Cosibelimab Daratumumab Drozitumab§ Duligotumab§ Dusigitumab§ Enfortumab
Minretumomab
proteins: Ardenermin Dulanermin Antibodies: Belimumab Brentuximab vedotin Conatumumab Dacetuzumab Denosumab Drozitumab Enavatuzumab Iratumumab Lexatumumab
Lymphotoxin_beta_receptor
Protein found in humans
proteins: Ardenermin Dulanermin Antibodies: Belimumab Brentuximab vedotin Conatumumab Dacetuzumab Denosumab Drozitumab Enavatuzumab Iratumumab Lexatumumab
Lymphotoxin_alpha
Membrane receptor protein found in humans
proteins: Ardenermin Dulanermin Antibodies: Belimumab Brentuximab vedotin Conatumumab Dacetuzumab Denosumab Drozitumab Enavatuzumab Iratumumab Lexatumumab
Tumor necrosis factor receptor 2
Tumor_necrosis_factor_receptor_2
Protein-coding gene in the species Homo sapiens
proteins: Ardenermin Dulanermin Antibodies: Belimumab Brentuximab vedotin Conatumumab Dacetuzumab Denosumab Drozitumab Enavatuzumab Iratumumab Lexatumumab
Lymphotoxin_beta
InterPro Family
proteins: Ardenermin Dulanermin Antibodies: Belimumab Brentuximab vedotin Conatumumab Dacetuzumab Denosumab Drozitumab Enavatuzumab Iratumumab Lexatumumab
Lymphotoxin
Membrane receptor protein found in humans
proteins: Ardenermin Dulanermin Antibodies: Belimumab Brentuximab vedotin Conatumumab Dacetuzumab Denosumab Drozitumab Enavatuzumab Iratumumab Lexatumumab
Tumor necrosis factor receptor 1
Tumor_necrosis_factor_receptor_1
Protein superfamily
proteins: Ardenermin Dulanermin Antibodies: Belimumab Brentuximab vedotin Conatumumab Dacetuzumab Denosumab Drozitumab Enavatuzumab Iratumumab Lexatumumab
Tumor necrosis factor superfamily
Tumor_necrosis_factor_superfamily
Pharmaceutical compound
(+hyaluronidase) Ascrinvacumab§ Balstilimab† Botensilimab Cixutumumab§ Conatumumab§ Cosibelimab Daratumumab Drozitumab§ Duligotumab§ Dusigitumab§ Enfortumab
Indium (111In) altumomab pentetate
Indium_(111In)_altumomab_pentetate
Pharmaceutical compound
(+hyaluronidase) Ascrinvacumab§ Balstilimab† Botensilimab Cixutumumab§ Conatumumab§ Cosibelimab Daratumumab Drozitumab§ Duligotumab§ Dusigitumab§ Enfortumab
Naptumomab_estafenatox
travel, tourism, insurance
CONATUMUMAB
CONATUMUMAB
CONATUMUMAB
CONATUMUMAB
CONATUMUMAB
CONATUMUMAB
CONATUMUMAB
CONATUMUMAB
CONATUMUMAB
travel, tourism, insurance